{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:23:02Z","timestamp":1793107382143,"version":"4.5.0"},"reference-count":211,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000836","name":"University of Liverpool","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jcf.2023.12.002","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T05:38:38Z","timestamp":1703137118000},"page":"12-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Standards for the care of people with cystic fibrosis; establishing and maintaining health"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6516-9083","authenticated-orcid":false,"given":"Kevin W","family":"Southern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Addy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Bevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urzula","family":"Borawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-R\u00e9gis","family":"Burgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Button","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Chansard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Chilvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwyneth","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"De Boeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Declercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Doumit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Drevinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Fajac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M","family":"Georgiopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Gursli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gramegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina ME","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J","family":"Hug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Lammertyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwina (Eddie) C.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Langley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Mayer-Hamblett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Mielus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Munck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Plant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Ploeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique Pougheon","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tacjana","family":"Pressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley S","family":"Quon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Radtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe L","family":"Saynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Shufer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"van Koningsbruggen-Rietschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2023.12.002_bib0001","article-title":"Standards for the care of people with cystic fibrosis (CF)","author":"Southern","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2023.09.008","article-title":"Standards for the care of people with cystic fibrosis (CF): a timely and accurate diagnosis","author":"Castellani","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcf.2022.10.002","article-title":"Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis","volume":"22","author":"Southern","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0004","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamapediatrics.2017.0206","article-title":"Effects of diagnosis by newborn screening for cystic fibrosis on weight and length in the first year of life","volume":"171","author":"Leung","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jcf.2023.12.002_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MPG.0000000000001956","article-title":"Nutritional status in the first 2 years of life in cystic fibrosis diagnosed by newborn screening","volume":"67","author":"Munck","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2023.12.002_bib0006","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1590\/1806-9282.64.11.1032","article-title":"The role of neonatal screening in nutritional evolution in the first 12 months after diagnosis of cystic fibrosis","volume":"64","author":"Martins","year":"2018","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"10.1016\/j.jcf.2023.12.002_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2016.10.045","article-title":"Differences in outcomes between early and late diagnosis of cystic fibrosis in the newborn screening era","volume":"181","author":"Coffey","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2023.12.002_bib0008","series-title":"Cystic fibrosis foundation patient registry 2021 annual data report","year":"2022"},{"key":"10.1016\/j.jcf.2023.12.002_bib0009","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1002\/ppul.25658","article-title":"Outcomes of infants born during the first 9 years of CF newborn screening in the United States: a retrospective cystic fibrosis foundation patient registry cohort study","volume":"56","author":"Martiniano","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0010","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jcf.2018.01.006","article-title":"Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis","volume":"17","author":"Sanders","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0011","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcf.2022.09.001","article-title":"Trajectories of early growth and subsequent lung function in cystic fibrosis: an observational study using UK and Canadian registry data","volume":"22","author":"Macdougall","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0012","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcf.2021.08.005","article-title":"Impact of guideline-recommended dietitian assessments on weight gain in infants with cystic fibrosis","volume":"21","author":"Ong","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jand.2020.03.015","article-title":"Academy of nutrition and dietetics: 2020 cystic fibrosis evidence analysis center evidence-based nutrition practice guideline","volume":"121","author":"McDonald","year":"2021","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.jcf.2023.12.002_bib0014","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","article-title":"ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis","volume":"35","author":"Turck","year":"2016","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jcf.2023.12.002_bib0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcf.2019.05.007","article-title":"Highlights from the nutrition guidelines for cystic fibrosis in Australia and New Zealand","volume":"19","author":"van der Haak","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093263","article-title":"Breastfeeding in cystic fibrosis: a systematic review on prevalence and potential benefits","volume":"13","author":"Colombo","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jcf.2023.12.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2015.02.049","article-title":"Associations between gut microbial colonization in early life and respiratory outcomes in cystic fibrosis","volume":"167","author":"Hoen","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2023.12.002_bib0018","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MPG.0000000000002415","article-title":"Lactation Consultation Sustains Breast Milk Intake in Infants With Cystic Fibrosis","volume":"69","author":"Miller","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2023.12.002_bib0019","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jpedsurg.2021.02.047","article-title":"Early management of meconium ileus in infants with cystic fibrosis: a prospective population cohort study","volume":"56","author":"Long","year":"2021","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jcf.2023.12.002_bib0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jcf.2019.09.008","article-title":"Differences in clinical outcomes of paediatric cystic fibrosis patients with and without meconium ileus","volume":"18","author":"Tan","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0021","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jcf.2019.07.003","article-title":"Risk factors for adverse outcome in infancy in meconium ileus cystic fibrosis infants: a multicentre Italian study","volume":"18","author":"Padoan","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0022","unstructured":"Orenti A., A. Z, A. J, van Rens J. ECFSPR Annual Report 2020. 2022. https:\/\/www.ecfs.eu\/sites\/default\/files\/ECFSPR_Report_2020_v1.0%20%2807Jun2022%29_website.pdf Date accessed: 16\/8\/2023."},{"key":"10.1016\/j.jcf.2023.12.002_bib0023","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3390\/nu14061216","article-title":"The changing landscape of nutrition in cystic fibrosis: the emergence of overweight and obesity","volume":"14","author":"Bailey","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jcf.2023.12.002_bib0024","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcf.2022.03.010","article-title":"Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry","volume":"21","author":"Szentpetery","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0025","series-title":"Overweight and cystic fibrosis: an unexpected challenge","author":"Gabel","year":"2021"},{"key":"10.1016\/j.jcf.2023.12.002_bib0026","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/nu15030479","article-title":"Nutritional care in children with cystic fibrosis","volume":"15","author":"Mariotti Zani","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.jcf.2023.12.002_bib0027","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcf.2019.08.028","article-title":"Micronutrient intake in children with cystic fibrosis in Sydney, Australia","volume":"19","author":"Tham","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0028","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jcf.2018.03.011","article-title":"Dietary intake of energy-dense, nutrient-poor and nutrient-dense food sources in children with cystic fibrosis","volume":"17","author":"Sutherland","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/nu12103126","article-title":"Adherence to dietary recommendations, nutrient intake adequacy and diet quality among pediatric cystic fibrosis patients: results from the GreeCF study","volume":"12","author":"Poulimeneas","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jcf.2023.12.002_bib0030","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jand.2020.03.016","article-title":"Dietary macronutrient distribution and nutrition outcomes in persons with cystic fibrosis: an evidence analysis center systematic review","volume":"121","author":"McDonald","year":"2021","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.jcf.2023.12.002_bib0031","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/mcn.12230","article-title":"Communicating hunger and satiation in the first 2 years of life: a systematic review","volume":"12","author":"McNally","year":"2016","journal-title":"Matern Child Nutr"},{"key":"10.1016\/j.jcf.2023.12.002_bib0032","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpeds.2009.09.001","article-title":"Cystic fibrosis foundation evidence-based guidelines for management of infants with cystic fibrosis","volume":"155","author":"D","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2023.12.002_bib0033","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jcf.2010.07.002","article-title":"Mealtime interactions in families of a child with cystic fibrosis: a meta-analysis","volume":"9","author":"Hammons","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0034","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-3-319-16387-1_17","article-title":"Behavioral interventions and anticipatory guidance","author":"Ryan","year":"2015","journal-title":"Nutrition in Cystic Fibrosis"},{"key":"10.1016\/j.jcf.2023.12.002_bib0035","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-1784","article-title":"Clinical practice guidelines from the cystic fibrosis foundation for preschoolers with cystic fibrosis","volume":"137","author":"Lahiri","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2023.12.002_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2023.05.010","article-title":"Nutritional considerations for a new era: a CF foundation position paper","author":"Leonard","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0037","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jcf.2012.03.004","article-title":"Cystic fibrosis research in allied health and nursing professions","volume":"11","author":"Bradley","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0038","unstructured":"Orenti A., Zolin A., Jung A., van Rens J. ECFSPR Annual Report 2021. 2023. https:\/\/www.ecfs.eu\/sites\/default\/files\/Annual%20Report_2021_09Jun2023.pdf Date accessed: 26 August 2023."},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2023.12.002_bib0039","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jcf.2017.06.011","article-title":"Pancreatic insufficiency in cystic fibrosis","volume":"16","author":"Singh","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0040","article-title":"Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis","volume":"8","author":"Ng","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0041","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jcf.2017.03.005","article-title":"Nutritional status, nutrient intake and use of enzyme supplements in paediatric patients with Cystic Fibrosis; a European multicentre study with reference to current guidelines","volume":"16","author":"Calvo-Lerma","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0042","article-title":"Pancreatic enzyme replacement therapy for people with cystic fibrosis","volume":"8","author":"Somaraju","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0043","article-title":"Pancreatic enzyme replacement therapy for people with cystic fibrosis","volume":"11","author":"Somaraju","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0044","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.3748\/wjg.v20.i33.11467","article-title":"Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21st century","volume":"20","author":"Trang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2213-2600(18)30202-9","article-title":"Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study","volume":"6","author":"Rosenfeld","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0046","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jcf.2019.03.009","article-title":"An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5years (KLIMB)","volume":"18","author":"Rosenfeld","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0047","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nut.2018.03.052","article-title":"Cystic fibrosis, body composition, and health outcomes: a systematic review","volume":"55-56","author":"Calella","year":"2018","journal-title":"Nutrition"},{"key":"10.1016\/j.jcf.2023.12.002_bib0048","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.3390\/nu13092907","article-title":"The impact of highly effective CFTR modulators on growth and nutrition status","volume":"13","author":"Bass","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jcf.2023.12.002_bib0049","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/ncp.10899","article-title":"Update on the management of vitamins and minerals in cystic fibrosis","volume":"37","author":"Sankararaman","year":"2022","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.jcf.2023.12.002_bib0050","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/MPG.0000000000002688","article-title":"Assessment and interpretation of vitamin and trace element status in sick children: a position paper from the european society for paediatric gastroenterology hepatology, and nutrition committee on nutrition","volume":"70","author":"Gerasimidis","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2023.12.002_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2023.08.002","article-title":"The impact of elexacaftor\/tezacaftor\/ivacaftor on fat-soluble vitamin levels in people with cystic fibrosis","author":"Hergenroeder","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2023.04.019","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on fat-soluble vitamin levels in children with cystic fibrosis","author":"Schembri","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0053","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jand.2020.05.011","article-title":"Sodium status and replacement in children and adults living with cystic fibrosis: a narrative review","volume":"120","author":"Declercq","year":"2020","journal-title":"J Acad Nutr Diet"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2023.12.002_bib0054","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.jcf.2019.08.017","article-title":"Cystic fibrosis bone disease treatment: current knowledge and future directions","volume":"18","author":"Putman","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0055","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1164\/rccm.201606-1107CI","article-title":"Early lung disease in infants and preschool children with cystic fibrosis. What have we learned and what should we do about it?","volume":"195","author":"Ranganathan","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0056","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00580-2017","article-title":"Elevated lung clearance index in infants with cystic fibrosis shortly after birth","volume":"50","author":"Kieninger","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2023.12.002_bib0057","unstructured":"IPG\/CF. Physiotherapy for people with Cystic Fibrosis: from infant to adult. 2018. www.ecfs.eu\/ipg_cf\/booklet."},{"key":"10.1016\/j.jcf.2023.12.002_bib0058","series-title":"The early cystic fibrosis years","first-page":"297","article-title":"Airway clearance and activity in the early pre-school years of children with cystic fibrosis","author":"McIlwaine","year":"2018"},{"key":"10.1016\/j.jcf.2023.12.002_bib0059","first-page":"263","article-title":"Physiotherapy in cystic fibrosis: optimising techniques to improve outcomes","volume":"14","author":"Rand","year":"2013","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0060","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00522-2023","article-title":"Real-world effectiveness of airway clearance techniques in children with cystic fibrosis","volume":"62","author":"Filipow","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2023.12.002_bib0061","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcf.2010.04.008","article-title":"Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening","volume":"9","author":"Sermet-Gaudelus","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0062","article-title":"Airway clearance techniques for cystic fibrosis: an overview of Cochrane systematic reviews","volume":"1","author":"Wilson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0063","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10225280","article-title":"Methods used to evaluate the immediate effects of airway clearance techniques in adults with cystic fibrosis: a systematic review and meta-analysis","volume":"10","author":"Chapman","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0064","article-title":"Airway clearance techniques compared to no airway clearance techniques for cystic fibrosis","volume":"4","author":"Warnock","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0065","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1080\/09593985.2021.2023932","article-title":"The physiotherapy consultation: a qualitative study of the experience of parents of infants with cystic fibrosis in Australia","volume":"39","author":"Andrews","year":"2023","journal-title":"Physiother Theory Pract"},{"key":"10.1016\/j.jcf.2023.12.002_bib0066","unstructured":"World Health Organisation. WHO guidelines on physical activity and sedentary behaviour. 2020. https:\/\/www.who.int\/publications-detail-redirect\/9789240015128."},{"key":"10.1016\/j.jcf.2023.12.002_bib0067","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmjspcare-2021-003019","article-title":"Experiences of fathers of children with a life-limiting condition: a systematic review and qualitative synthesis","volume":"13","author":"Fisher","year":"2023","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.jcf.2023.12.002_bib0068","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1097\/DBP.0000000000001089","article-title":"Parenting children with cystic fibrosis: developmental acquisition of expertise","volume":"43","author":"Tluczek","year":"2022","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.jcf.2023.12.002_bib0069","series-title":"The early cystic fibrosis years","first-page":"297","article-title":"Airway clearance and activity in the early pre-school years of children with cystic fibrosis","author":"Mcllwaine","year":"2018"},{"key":"10.1016\/j.jcf.2023.12.002_bib0070","doi-asserted-by":"crossref","DOI":"10.1177\/2050312117697505","article-title":"Evaluation of a novel technique in airway clearance therapy - specific Cough Technique (SCT) in cystic fibrosis: a pilot study of a series of N-of-1 randomised controlled trials","volume":"5","author":"Gursli","year":"2017","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0071","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2021-001057","article-title":"Daily life participation in childhood chronic disease: a qualitative study on the child's and parent's perspective","volume":"5","author":"Nap-van der Vlist","year":"2021","journal-title":"BMJ Paediatr Open"},{"key":"10.1016\/j.jcf.2023.12.002_bib0072","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/cch.12860","article-title":"Thriving alongside cystic fibrosis: developing a grounded theory of empowerment in children and young people with cystic fibrosis during key life transitions","volume":"47","author":"Fairweather","year":"2021","journal-title":"Child Care Health Dev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0073","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4187\/respcare.06500","article-title":"Persistent adherence to airway clearance therapy in adults with cystic fibrosis","volume":"64","author":"Sherman","year":"2019","journal-title":"Respir Care"},{"key":"10.1016\/j.jcf.2023.12.002_bib0074","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276310","article-title":"Airway clearance physiotherapy and health-related quality of life in cystic fibrosis","volume":"17","author":"Gursli","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2023.12.002_bib0075","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s10880-018-9598-z","article-title":"Identifying factors that facilitate treatment adherence in cystic fibrosis: qualitative analyses of interviews with parents and adolescents","volume":"26","author":"Nicolais","year":"2019","journal-title":"J Clin Psychol Med Settings"},{"key":"10.1016\/j.jcf.2023.12.002_bib0076","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2020-000601","article-title":"What effective ways of motivation, support and technologies help people with cystic fibrosis improve and sustain adherence to treatment?","volume":"7","author":"Calthorpe","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jcf.2023.12.002_bib0077","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.adolescence.2019.07.006","article-title":"Developing agency in the transition to self-management of cystic fibrosis in young people","volume":"75","author":"Cronly","year":"2019","journal-title":"J Adolesc"},{"key":"10.1016\/j.jcf.2023.12.002_bib0078","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.pedn.2020.11.013","article-title":"The effect of self-efficacy, social support and quality of life on readiness for transition to adult care among adolescents with cystic fibrosis in Turkey","volume":"57","author":"Torun","year":"2021","journal-title":"J Pediatr Nurs"},{"key":"10.1016\/j.jcf.2023.12.002_bib0079","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.4187\/respcare.08260","article-title":"Transition from pediatric to adult care for young adults with chronic respiratory disease","volume":"65","author":"Willis","year":"2020","journal-title":"Respir Care"},{"key":"10.1016\/j.jcf.2023.12.002_bib0080","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.pedhc.2020.02.001","article-title":"It is a life journey: a roadmap of teens with chronic diseases in transitioning to independence","volume":"34","author":"Sezgin","year":"2020","journal-title":"J Pediatr Health Care"},{"key":"10.1016\/j.jcf.2023.12.002_bib0081","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.pec.2018.06.004","article-title":"Cystic fibrosis-related education: are we meeting patient and caregiver expectations?","volume":"101","author":"Lonabaugh","year":"2018","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jcf.2023.12.002_bib0082","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/1367493518768448","article-title":"Transition from paediatric to adult healthcare for young people with cystic fibrosis: parents' information needs","volume":"22","author":"Coyne","year":"2018","journal-title":"J Child Health Care"},{"key":"10.1016\/j.jcf.2023.12.002_bib0083","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/ppul.24655","article-title":"Clinical communication preferences in cystic fibrosis and strategies to optimize care","volume":"55","author":"Cooley","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0084","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1037\/ccp0000250","article-title":"A meta-analysis of motivational interviewing process: technical, relational, and conditional process models of change","volume":"86","author":"Magill","year":"2018","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0085","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s13346-022-01131-8","article-title":"Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach","volume":"12","author":"Abrami","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.jcf.2023.12.002_bib0086","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01793-2018","article-title":"Effects of exercise and airway clearance (positive expiratory pressure) on mucus clearance in cystic fibrosis: a randomised crossover trial","volume":"53","author":"Dwyer","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2023.12.002_bib0087","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/thoraxjnl-2012-202915","article-title":"Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis","volume":"68","author":"McIlwaine","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2023.12.002_bib0088","unstructured":"CF Trust. Physiotherapy standards of care and good clinical practice for the physiotherapy management of cystic fibrosis. 2020. https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2020-12\/Standards%20of%20Care%20and%20Good%20Clinical%20Practice%20for%20the%20Physiotherapy%20Management%20of%20Cystic%20Fibrosis%20Fourth%20edition%20December%202020.pdf."},{"key":"10.1016\/j.jcf.2023.12.002_bib0089","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcf.2022.09.008","article-title":"Quantity and quality of airway clearance in children and young people with cystic fibrosis","volume":"22","author":"Raywood","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0090","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/thoraxjnl-2017-210473","article-title":"The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers","volume":"73","author":"Rowbotham","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2023.12.002_bib0091","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/thorax-2022-219213","article-title":"Exercise as airway clearance therapy (ExACT) in cystic fibrosis: a UK-based e-Delphi survey of patients, caregivers and health professionals","volume":"78","author":"Saynor","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2023.12.002_bib0092","doi-asserted-by":"crossref","first-page":"xiii","DOI":"10.1016\/j.ccm.2022.07.003","article-title":"Cystic fibrosis in the era of highly effective CFTR modulators","volume":"43","author":"Britto","year":"2022","journal-title":"Clin Chest Med"},{"issue":"Suppl 3","key":"10.1016\/j.jcf.2023.12.002_bib0093","first-page":"S46","article-title":"Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators","volume":"54","author":"Perrem","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0094","doi-asserted-by":"crossref","DOI":"10.3390\/cells11071243","article-title":"CFTR modulator therapies: potential impact on airway infections in cystic fibrosis","volume":"11","author":"Saluzzo","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.jcf.2023.12.002_bib0095","first-page":"1","article-title":"Chronic rhinosinusitis in cystic fibrosis: a review of therapeutic options","volume":"279","author":"Krajewska","year":"2022","journal-title":"Eur Arch Oto-rhino-Laryngol: Official J Eur Federat Oto-Rhino-Laryngol Soc (EUFOS): Affiliated German Soc Oto-Rhino-Laryngol - Head Neck Surgery"},{"key":"10.1016\/j.jcf.2023.12.002_bib0096","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/lio2.401","article-title":"Chronic rhinosinusitis in patients with cystic fibrosis-current management and new treatments","volume":"5","author":"BJ","year":"2020","journal-title":"Laryngoscope Investigat Otolaryngol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0097","doi-asserted-by":"crossref","DOI":"10.1002\/lary.30642","article-title":"Upper airway disease in adults with cystic fibrosis in the era of <scp>CFTR<\/scp>modulators","author":"Uyttebroek","year":"2023","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jcf.2023.12.002_bib0098","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/lary.24503","article-title":"Medical management of chronic rhinosinusitis in cystic fibrosis: a systematic review","volume":"124","author":"Liang","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jcf.2023.12.002_bib0099","article-title":"Medical interventions for chronic rhinosinusitis in cystic fibrosis","volume":"4","author":"Karanth","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/DDDT.S54064","article-title":"Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study","volume":"8","author":"Mainz","year":"2014","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.jcf.2023.12.002_bib0101","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2500\/ajra.2013.27.3829","article-title":"The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis","volume":"27","author":"Aanaes","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jcf.2023.12.002_bib0102","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/alr.22082","article-title":"Treatment of chronic rhinosinusitis with dornase alfa in patients with cystic fibrosis: a systematic review","volume":"8","author":"Shah","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0103","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcf.2022.03.002","article-title":"Elexacaftor-tezacaftor- ivacaftor improves sinonasal outcomes in cystic fibrosis","volume":"21","author":"Stapleton","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0104","unstructured":"Action on Smoking and Health (ASH). Use of e-cigarettes (vapes) among young people in Great Britain. 2023. https:\/\/ash.org.uk\/uploads\/Use-of-vapes-among-young-people-GB-2023.pdf?v=1686042690 Date accessed: 1 August 2023."},{"key":"10.1016\/j.jcf.2023.12.002_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2022.110952","article-title":"A systematic review examining the pulmonary effects of electronic vapor delivery systems","volume":"82","author":"Novelli","year":"2022","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.jcf.2023.12.002_bib0106","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1165\/rcmb.2019-0016ED","article-title":"Vaping away epithelial integrity","volume":"61","author":"Gaurav","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0107","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1440-1843.2012.02194.x","article-title":"Comparison of pulmonary function and respiratory symptoms in water pipe and cigarette smokers","volume":"17","author":"Boskabady","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.jcf.2023.12.002_bib0108","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4103\/0970-2113.135763","article-title":"Prevalence of water pipe smoking in the city of Mashhad (North East of Iran) and its effect on respiratory symptoms and pulmonary function tests","volume":"31","author":"Boskabady","year":"2014","journal-title":"Lung India"},{"key":"10.1016\/j.jcf.2023.12.002_bib0109","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1164\/rccm.201512-2470OC","article-title":"Pulmonary abnormalities in young, light-use waterpipe (Hookah) smokers","volume":"194","author":"Strulovici-Barel","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0110","unstructured":"American Cancer Society. Health risks of secondhand smoke. 2023. prevention\/tobacco\/health-risks-of-tobacco\/secondhand-smoke.html#:~:text=Secondhand%20smoke%20(SHS)%20is%20also,tobacco%20burning%20in%20a%20hookah Date accessed: 1 August 2023."},{"key":"10.1016\/j.jcf.2023.12.002_bib0111","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/rccm.201806-1110OC","article-title":"Cardiopulmonary exercise testing provides additional prognostic information in cystic fibrosis","volume":"199","author":"Hebestreit","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0112","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/ajrccm.164.3.2007168","article-title":"Exercise inhibits epithelial sodium channels in patients with cystic fibrosis","volume":"164","author":"Hebestreit","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0113","article-title":"Physical activity and exercise training in cystic fibrosis","author":"Radtke","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0114","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1183\/09031936.00055513","article-title":"Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis","volume":"43","author":"Schneiderman","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2023.12.002_bib0115","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.jcf.2021.08.004","article-title":"Rethinking physical exercise training in the modern era of cystic fibrosis: a step towards optimising short-term efficacy and long-term engagement","volume":"21","author":"Gruet","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0116","doi-asserted-by":"crossref","first-page":"7133","DOI":"10.3390\/ijerph19127133","article-title":"Sleep, sedentary time and physical activity levels in children with cystic fibrosis","volume":"19","author":"Bianchim","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jcf.2023.12.002_bib0117","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12931-023-02451-0","article-title":"Heterogeneity of weight gain after initiation of Elexacaftor\/Tezacaftor\/Ivacaftor in people with cystic fibrosis","volume":"24","author":"Gramegna","year":"2023","journal-title":"Respir Res"},{"key":"10.1016\/j.jcf.2023.12.002_bib0118","article-title":"Obesity in cystic fibrosis","volume":"26","author":"Kutney","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0119","article-title":"Overweight and obesity in adults with cystic fibrosis: an Italian multicenter cohort study","author":"Gramegna","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s44161-022-00030-y","article-title":"Identifying and preventing cardiovascular disease in patients with cystic fibrosis","volume":"1","author":"Saunders","year":"2022","journal-title":"Nature Cardiovasc Res"},{"key":"10.1016\/j.jcf.2023.12.002_bib0121","article-title":"Cardiovascular complications in cystic fibrosis: a review of the literature","author":"Poore","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0122","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00174-2023","article-title":"Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study","author":"Frost","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2023.12.002_bib0123","article-title":"Exercise versus airway clearance techniques for people with cystic fibrosis","author":"Heinz","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0124","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/thoraxjnl-2020-215836","article-title":"Exercise as a substitute for traditional airway clearance in cystic fibrosis: a systematic review","volume":"76","author":"Ward","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2023.12.002_bib0125","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000439057","article-title":"Statement on exercise testing in cystic fibrosis","volume":"90","author":"Hebestreit","year":"2015","journal-title":"Respiration"},{"key":"10.1016\/j.jcf.2023.12.002_bib0126","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0029-2023","article-title":"Guidance and standard operating procedures for functional exercise testing in cystic fibrosis","volume":"32","author":"Saynor","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272355","article-title":"Developing an ecological approach to physical activity promotion in adults with Cystic fibrosis","volume":"17","author":"Shelley","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2023.12.002_bib0128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/17476348.2019.1552833","article-title":"Current perspectives of physical activity in cystic fibrosis","volume":"13","author":"Cox","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0129","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jcf.2010.05.006","article-title":"Risks associated with exercise testing and sports participation in cystic fibrosis","volume":"9","author":"Ruf","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcf.2008.09.008","article-title":"Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis","volume":"8","author":"Ruf","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0131","doi-asserted-by":"crossref","DOI":"10.1177\/14799731221121670","article-title":"The Exeter Activity Unlimited statement on physical activity and exercise for cystic fibrosis: methodology and results of an international, multidisciplinary, evidence-driven expert consensus","volume":"19","author":"Williams","year":"2022","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.jcf.2023.12.002_bib0132","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12887-018-1301-x","article-title":"A formative study exploring perceptions of physical activity and physical activity monitoring among children and young people with cystic fibrosis and health care professionals","volume":"18","author":"Shelley","year":"2018","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jcf.2023.12.002_bib0133","doi-asserted-by":"crossref","first-page":"13150","DOI":"10.3390\/ijerph192013150","article-title":"Barriers for sports and exercise participation and corresponding barrier management in cystic fibrosis","volume":"19","author":"Dillenhoefer","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jcf.2023.12.002_bib0134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229296","article-title":"Radtke T. Perceptions towards physical activity in adult lung transplant recipients with cystic fibrosis","volume":"15","author":"Wietlisbach","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2023.12.002_bib0135","article-title":"Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis","volume":"6","author":"Pinto","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2023.12.002_bib0136","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2014.03.009","article-title":"European cystic fibrosis society standards of care: framework for the cystic fibrosis centre","volume":"13","author":"Conway","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0137","article-title":"The future of cystic fibrosis care: a global perspective","author":"Bell","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0138","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2023.02.004","article-title":"Elexacaftor\/tezacaftor\/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del","author":"Lopez","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"Suppl 3","key":"10.1016\/j.jcf.2023.12.002_bib0139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcf.2021.09.002","article-title":"Impact of the COVID-19 pandemic: how our response is shaping the future of cystic fibrosis care","volume":"20","author":"Sabadosa","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0140","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/24694193.2021.1936294","article-title":"Youth work in the hospital setting: a narrative review of the literature","volume":"46","author":"Marshall","year":"2023","journal-title":"Compr Child Adolesc Nurs"},{"key":"10.1016\/j.jcf.2023.12.002_bib0141","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11050418","article-title":"Fertility, pregnancy and lactation considerations for women with CF in the CFTR modulator era","volume":"11","author":"Jain","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0142","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0042-1758731","article-title":"Advanced cystic fibrosis lung disease and lung transplantation in the era of cystic fibrosis transmembrane conductance regulator modulators","volume":"44","author":"O'Carroll","year":"2023","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0143","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ccm.2022.07.002","article-title":"Update on lung transplantation for cystic fibrosis","volume":"43","author":"Pilewski","year":"2022","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0144","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcf.2022.07.002","article-title":"Telehealth and CFTR modulators: accelerating innovative models of cystic fibrosis care","volume":"22","author":"Prickett","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0146","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jcf.2023.05.012","article-title":"Telehealth in Cystic Fibrosis. A systematic review incorporating a novel scoring system and expert weighting to identify a 'top 10 manuscripts' to inform future best practices implementation","volume":"22","author":"Vagg","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0147","article-title":"Partnership enhancement program: piloting a communication training program for cystic fibrosis care teams","volume":"8","author":"George","year":"2021","journal-title":"J Patient Exp"},{"key":"10.1016\/j.jcf.2023.12.002_bib0148","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13023-023-02640-6","article-title":"A conceptual framework to develop a patient-reported experience questionnaire on the cystic fibrosis journey in France: the ExPaParM collaborative study","volume":"18","author":"Pougheon Bertrand","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jcf.2023.12.002_bib0149","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jcf.2018.06.006","article-title":"Using registry data to improve quality of care","volume":"17","author":"McIntyre","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","author":"Guo","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0151","article-title":"Digital technology for early identification of exacerbations in people with cystic fibrosis","volume":"4","author":"Wong","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0152","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/thoraxjnl-2021-217594","article-title":"Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial","volume":"77","author":"Wildman","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2023.12.002_bib0153","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/thorax-2022-218702","article-title":"Web-based physical activity promotion in young people with CF: a randomised controlled trial","volume":"78","author":"Cox","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2023.12.002_bib0154","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1164\/rccm.201610-2172OC","article-title":"Home monitoring of patients with cystic fibrosis to identify and treat acute pulmonary exacerbations. eICE study results","volume":"196","author":"Lechtzin","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0155","article-title":"Adherence, reliability, and variability of home spirometry telemonitoring in cystic fibrosis","volume":"11","author":"Beaufils","year":"2023","journal-title":"Front Pediat"},{"key":"10.1016\/j.jcf.2023.12.002_bib0156","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2021.08.013","article-title":"A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis","volume":"21","author":"Paynter","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0157","article-title":"Quantifying variation in home spirometry in people with cystic fibrosis during baseline health, and associations with clinical outcomes","author":"Thornton","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0158","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1002\/ppul.24932","article-title":"Technical validity and usability of a novel smartphone-connected spirometry device for pediatric patients with asthma and cystic fibrosis","volume":"55","author":"Kruizinga","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0159","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1002\/ppul.26147","article-title":"Real-world feasibility of short-term, unsupervised home spirometry in CF","volume":"57","author":"Davis","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0160","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1513\/AnnalsATS.202012-1484RL","article-title":"Favorable clinician acceptability of telehealth as part of the cystic fibrosis care model during the COVID-19 pandemic","volume":"18","author":"Perkins","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2023.12.002_bib0161","doi-asserted-by":"crossref","DOI":"10.1177\/17534666211070133","article-title":"A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis","volume":"16","author":"Nash","year":"2022","journal-title":"Ther Adv Respir Dis"},{"issue":"Suppl 3","key":"10.1016\/j.jcf.2023.12.002_bib0162","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2021.09.006","article-title":"Telehealth use in cystic fibrosis during COVID-19: association with race, ethnicity, and socioeconomic factors","volume":"20","author":"Albon","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0163","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13102-021-00323-y","article-title":"Feasibility and implementation of a personalized, web-based exercise intervention for people with cystic fibrosis for 1 year","volume":"13","author":"Hillen","year":"2021","journal-title":"BMC Sports Sci Med Rehabil"},{"key":"10.1016\/j.jcf.2023.12.002_bib0164","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/ppul.25413","article-title":"Psychological interventions during COVID pandemic: telehealth for individuals with cystic fibrosis and caregivers","volume":"56","author":"Graziano","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0165","article-title":"Managing Cystic Fibrosis related diabetes via telehealth during COVID-19 pandemic","volume":"23","author":"Hasan","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0166","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.japh.2018.01.006","article-title":"The pharmacist's role in supporting people living with cystic fibrosis","volume":"58","author":"Abraham","year":"2018","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.jcf.2023.12.002_bib0167","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/ppul.25283","article-title":"Understanding the expanding role of pharmacy services in outpatient cystic fibrosis care","volume":"56","author":"Zobell","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0168","series-title":"Hospital pharmacy Europe","article-title":"Role of the clinical pharmacist in the management of CF","author":"Thompson","year":"2016"},{"key":"10.1016\/j.jcf.2023.12.002_bib0169","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/thoraxjnl-2021-217140","article-title":"Exploring the challenges of accessing medication for patients with cystic fibrosis","volume":"77","author":"Herbert","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2023.12.002_bib0170","first-page":"1","article-title":"Development and preliminary validation of the challenges of living with cystic fibrosis (CLCF) questionnaire: a 46-item measure of treatment burden for parent\/carers of children with CF","author":"Glasscoe","year":"2022","journal-title":"Psychol Health"},{"key":"10.1016\/j.jcf.2023.12.002_bib0171","doi-asserted-by":"crossref","first-page":"258","DOI":"10.11124\/JBISRIR-2016-002362","article-title":"Experiences of adults with cystic fibrosis in adhering to medication regimens: a qualitative systematic review","volume":"14","author":"Macdonald","year":"2016","journal-title":"JBI Database System Rev Implement Rep"},{"key":"10.1016\/j.jcf.2023.12.002_bib0172","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1378\/chest.09-3074","article-title":"Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers","volume":"140","author":"Daniels","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2023.12.002_bib0173","article-title":"Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis","volume":"2","author":"Smith","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0174","article-title":"Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis","volume":"3","author":"Dawson","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0175","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S2213-2600(22)00434-9","article-title":"Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials","volume":"11","author":"Mayer-Hamblett","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0176","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1164\/rccm.202008-3177OC","article-title":"Ivacaftor in infants aged 4 to <12 months with cystic fibrosis and a gating mutation. results of a two-part phase 3 clinical trial","volume":"203","author":"Davies","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0177","unstructured":"European Medicines Agency. Orkambi EPAR. 2023. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/orkambi-epar-product-information_en.pdf Date accessed: 28 September 2023."},{"key":"10.1016\/j.jcf.2023.12.002_bib0178","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.202301-0084OC","article-title":"Phase 3 open-label clinical trial of elexacaftor\/tezacaftor\/ivacaftor in children aged 2-5 years with cystic fibrosis and at least one F508del allele","volume":"208","author":"Goralski","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0179","article-title":"Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)","volume":"12","author":"Southern","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.12.002_bib0180","series-title":"2021 Annual data report","year":"2023"},{"key":"10.1016\/j.jcf.2023.12.002_bib0181","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jcf.2022.09.002","article-title":"Drug-induced acne with elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis","volume":"21","author":"Hudson","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0182","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0183","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jcf.2022.04.010","article-title":"Onset of systemic arterial hypertension after initiation of elexacaftor\/tezacaftor\/ivacaftor in adults with cystic fibrosis: a case series","volume":"21","author":"Gramegna","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0184","unstructured":"European Medicines Agency. Kaftrio summary of product characteristics. 2020. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kaftrio Date accessed: 1 July 2021."},{"key":"10.1016\/j.jcf.2023.12.002_bib0185","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1164\/rccm.201906-1227OC","article-title":"Real-life safety and effectiveness of lumacaftor-ivacaftor in patients with cystic fibrosis","volume":"201","author":"Burgel","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0186","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10010023","article-title":"Real-world safety of CFTR modulators in the treatment of cystic fibrosis: a systematic review","volume":"10","author":"Dagenais","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0187","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jcf.2023.01.015","article-title":"Suicide attempts in adolescents with cystic fibrosis on Elexacaftor\/Tezacaftor\/Ivacaftor therapy","volume":"22","author":"Arslan","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0188","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jcf.2022.05.001","article-title":"Dose adjustments of Elexacaftor\/Tezacaftor\/Ivacaftor in response to mental health side effects in adults with cystic fibrosis","volume":"21","author":"Spoletini","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0189","doi-asserted-by":"crossref","DOI":"10.1177\/17534666221144211","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on depression and anxiety in cystic fibrosis","volume":"16","author":"Zhang","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.jcf.2023.12.002_bib0190","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/ppul.26412","article-title":"Management of neuropsychiatric symptoms in adults treated with elexacaftor\/tezacaftor\/ivacaftor","volume":"58","author":"Baroud","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0191","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(22)01012-8","article-title":"Highly-effective modulator therapies: impact on the well-being of people living with cystic fibrosis and implications for the CF care model","author":"Van Citters","year":"2022","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1016\/j.jcf.2023.12.002_bib0192","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.26527","article-title":"Positive and negative impacts of elexacaftor\/tezacaftor\/ivacaftor: healthcare providers' observations across US centers","author":"Bathgate","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0193","unstructured":"European Medicines Agency. Committee for medicinal products for human use (CHMP) Minutes for the meeting on 22-25 May 2023. 2023. https:\/\/www.ema.europa.eu\/en\/documents\/minutes\/minutes-chmp-meeting-22-25-may-2023_en.pdf Date accessed: 28 September 2023."},{"key":"10.1016\/j.jcf.2023.12.002_bib0194","unstructured":"Agency MaHpR. Ivacaftor, tezacaftor, elexacaftor (Kaftrio\u25bc) in combination with ivacaftor (Kalydeco): risk of serious liver injury; updated advice on liver function testing. 2023. https:\/\/www.gov.uk\/drug-safety-update\/ivacaftor-tezacaftor-elexacaftor-kaftriov-in-combination-with-ivacaftor-kalydeco-risk-of-serious-liver-injury-updated-advice-on-liver-function-testing Date accessed: 28 September 2023."},{"key":"10.1016\/j.jcf.2023.12.002_bib0195","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1164\/rccm.202303-0380LE","article-title":"Raised intracranial pressure in three children with cystic fibrosis receiving elexacaftor-tezacaftor-ivacaftor modulator therapy","volume":"208","author":"Southern","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.12.002_bib0196","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jcjo.2021.04.018","article-title":"Papilledema and hypervitaminosis A after elexacaftor\/tezacaftor\/ivacaftor for cystic fibrosis","volume":"57","author":"Miller","year":"2022","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0197","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jcf.2022.06.011","article-title":"A case of Elexacaftor-Tezacaftor-Ivacaftor induced rash resolving without interruption of treatment","volume":"21","author":"Bhaskaran","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0198","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-247042","article-title":"Elexacaftor, tezacaftor and ivacaftor: a case of severe rash and approach to desensitisation","volume":"15","author":"Cheng","year":"2022","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jcf.2023.12.002_bib0199","first-page":"463","article-title":"Rechallenge of elexacaftor\/tezacaftor\/ivacaftor after skin rash in two pediatric patients","volume":"27","author":"Diseroad","year":"2022","journal-title":"J Pediatric Pharmacol Therapeut: JPPT: Official J PPAG"},{"key":"10.1016\/j.jcf.2023.12.002_bib0200","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.anai.2021.08.010","article-title":"Elexacaftor\/tezacaftor\/ivacaftor outpatient desensitization","volume":"128","author":"Balijepally","year":"2022","journal-title":"Ann Allergy, Asthma Immunol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0201","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jcf.2023.01.007","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on liver tests at a large single adult cystic fibrosis centre","volume":"22","author":"Tewkesbury","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0202","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.psym.2017.04.001","article-title":"Cystic fibrosis transmembrane regulator modulators: implications for the management of depression and anxiety in cystic fibrosis","volume":"58","author":"Talwalkar","year":"2017","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jcf.2023.12.002_bib0203","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1156621","article-title":"Individualized approach to elexacaftor\/tezacaftor\/ivacaftor dosing in cystic fibrosis, in response to self-reported anxiety and neurocognitive adverse events: a case series","volume":"14","author":"Ibrahim","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcf.2023.12.002_bib0204","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/j.jcf.2022.01.010","article-title":"Hypervitaminosis A with fulminant secondary intracranial hypertension following personalized medicine-based Elexacaftor\/Tezacaftor\/Ivacaftor initiation in a preadolescent with cystic fibrosis","volume":"21","author":"Wisniewski","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.12.002_bib0205","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3390\/pharmaceutics14081674","article-title":"Therapeutic Drug Monitoring of Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis: where Are We Now?","volume":"14","author":"Choong","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jcf.2023.12.002_bib0206","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/biomedicines11020628","article-title":"Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients' Plasma by a Novel LC-MS\/MS Method","volume":"11","author":"Pigliasco","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jcf.2023.12.002_bib0207","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/phar.2786","article-title":"Safety of elexacaftor\/tezacaftor\/ivacaftor dose reduction: mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series","volume":"43","author":"Hong","year":"2023","journal-title":"Pharmacotherapy: J Human Pharmacol Drug Therapy"},{"key":"10.1016\/j.jcf.2023.12.002_bib0208","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001289","article-title":"Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design","volume":"9","author":"Jain","year":"2022","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jcf.2023.12.002_bib0209","article-title":"Management of pregnancy in cystic fibrosis","volume":"18","author":"Montemayor","year":"2022","journal-title":"Breathe (Sheff)"},{"key":"10.1016\/j.jcf.2023.12.002_bib0210","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.clinthera.2023.01.016","article-title":"The impact of highly effective cystic fibrosis transmembrane conductance regulator modulators on the health of female subjects with cystic fibrosis","volume":"45","author":"Taylor-Cousar","year":"2023","journal-title":"Clin Ther"},{"key":"10.1016\/j.jcf.2023.12.002_bib0211","article-title":"Canadian clinical consensus guideline for initiation","year":"2022","journal-title":"Monitoring and discontinuation of CFTR modulator therapies for patients with cystic fibrosis"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323017277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323017277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T04:11:13Z","timestamp":1767240673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323017277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":211,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1569199323017277"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.12.002","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standards for the care of people with cystic fibrosis; establishing and maintaining health","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}